Keap1 hypomorphism protects against ischemic and obstructive kidney disease
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Keap1 hypomorphism protects against ischemic and obstructive kidney disease
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-11-02
DOI
10.1038/srep36185
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Translational value of animal models of kidney failure
- (2015) Alberto Ortiz et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Dose-dependent deleterious and salutary actions of the Nrf2 inducer dh404 in chronic kidney disease
- (2015) Nosratola D. Vaziri et al. FREE RADICAL BIOLOGY AND MEDICINE
- Extracellular Superoxide Dismutase Protects against Proteinuric Kidney Disease
- (2015) R. J. Tan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Sustained Activation of Wnt/ -Catenin Signaling Drives AKI to CKD Progression
- (2015) L. Xiao et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Progression after AKI: Understanding Maladaptive Repair Processes to Predict and Identify Therapeutic Treatments
- (2015) D. P. Basile et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Inflammation in AKI: Current Understanding, Key Questions, and Knowledge Gaps
- (2015) H. Rabb et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Integrated transcriptomic and proteomic analyses uncover regulatory roles of Nrf2 in the kidney
- (2015) Luke M. Shelton et al. KIDNEY INTERNATIONAL
- Derivative of Bardoxolone Methyl, dh404, in an Inverse Dose-Dependent Manner Lessens Diabetes-Associated Atherosclerosis and Improves Diabetic Kidney Disease
- (2014) S. M. Tan et al. DIABETES
- Bardoxolone methyl (BARD) ameliorates aristolochic acid (AA)-induced acute kidney injury through Nrf2 pathway
- (2014) Juan Wu et al. TOXICOLOGY
- Wnt/β-catenin signaling and kidney fibrosis
- (2014) Roderick J. Tan et al. Kidney International Supplements
- Loss of Klotho Contributes to Kidney Injury by Derepression of Wnt/ -Catenin Signaling
- (2013) L. Zhou et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease
- (2013) Stacey Ruiz et al. KIDNEY INTERNATIONAL
- Reading between the (guide)lines—the KDIGO practice guideline on acute kidney injury in the individual patient
- (2013) Mark D. Okusa et al. KIDNEY INTERNATIONAL
- Nrf2 suppresses lupus nephritis through inhibition of oxidative injury and the NF-κB-mediated inflammatory response
- (2013) Tao Jiang et al. KIDNEY INTERNATIONAL
- The Nrf2 triterpenoid activator, CDDO-imidazolide, protects kidneys from ischemia–reperfusion injury in mice
- (2013) Manchang Liu et al. KIDNEY INTERNATIONAL
- Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy
- (2013) Linda F. Fried et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
- (2013) Dick de Zeeuw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Endothelin Receptor A Blockade Is an Ineffective Treatment for Adriamycin Nephropathy
- (2013) Roderick J. Tan et al. PLoS One
- Superoxide dismutase 3 is induced by antioxidants, inhibits oxidative DNA damage and is associated with inhibition of estrogen-induced breast cancer
- (2012) Bhupendra Singh et al. CARCINOGENESIS
- Improving the efficacy of RAAS blockade in patients with chronic kidney disease
- (2012) Hiddo J. Lambers Heerspink et al. Nature Reviews Nephrology
- Therapeutic Potential of Nrf2 Activators in Streptozotocin-Induced Diabetic Nephropathy
- (2011) Hongting Zheng et al. DIABETES
- Matrix Metalloproteinase-7 as a Surrogate Marker Predicts Renal Wnt/ -Catenin Activity in CKD
- (2011) W. He et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Cellular and molecular mechanisms of renal fibrosis
- (2011) Youhua Liu Nature Reviews Nephrology
- Bardoxolone Methyl, Chronic Kidney Disease, and Type 2 Diabetes
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes
- (2011) Pablo E. Pergola et al. NEW ENGLAND JOURNAL OF MEDICINE
- Transcriptional Regulation of Renal Cytoprotective Genes by Nrf2 and Its Potential Use as a Therapeutic Target to Mitigate Cisplatin-Induced Nephrotoxicity
- (2010) L. M. Aleksunes et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Genetic Analysis of Cytoprotective Functions Supported by Graded Expression of Keap1
- (2010) K. Taguchi et al. MOLECULAR AND CELLULAR BIOLOGY
- Transcription factor Nrf2 is protective during ischemic and nephrotoxic acute kidney injury in mice
- (2009) Manchang Liu et al. KIDNEY INTERNATIONAL
- Sulforaphane protects kidneys against ischemia-reperfusion injury through induction of the Nrf2-dependent phase 2 enzyme
- (2008) Ha-Yong Yoon et al. BIOCHEMICAL PHARMACOLOGY
- The Cytokine TWEAK Modulates Renal Tubulointerstitial Inflammation
- (2008) A. B. Sanz et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Renal ischemia-reperfusion leads to long term infiltration of activated and effector-memory T lymphocytes
- (2008) Miguel Ascon et al. KIDNEY INTERNATIONAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search